About Synvect
Synvect is a Healthcare company based in San Diego (United States) founded in 2022. CRISPR-based mosquito control solutions are developed for disease reduction. Synvect has raised $3 million across 1 funding round from investors including Gates Foundation, Antler and NuFund. Synvect offers products and services including Suppression Box. Its focus areas include Life Sciences, Genomics, Applied Genomics and Other Applications. Its competitors include Biota, BaseTrace and Integrated Lipid Biofuels; 1 of its 3 listed competitors has raised funding.
Company details
Synvect was founded in 2022 in San Diego, United States, within the biotechnology sector. Operations focus on genetic modification of mosquito eggs using CRISPR knockouts to produce sterile, non-biting male mosquitoes. These males are released to mate with wild populations, thereby suppressing mosquito numbers and limiting disease transmission. Eggs are modified in laboratories and packaged for distribution and deployment worldwide.
- Headquarters San Diego, United States
- SectorsHealthcare
- Email••••••••
- Website synvect.com
- Social LinkedIn
- Total Equity Funding$3M (USD)
in 1 rounds
- Latest Funding Round$3M (USD), Seed
Mar 2025
- InvestorsGates Foundation
& 3 more
Products & Services of Synvect
Synvect offers a comprehensive portfolio of products and services, including Suppression Box.
Contains sterilized mosquito eggs for deployment to suppress wild populations effectively
Funding Insights of Synvect
Synvect has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Seed round of $3 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 1
- Last Round Seed — $3M
- First Round $3M
(Mar 2025)
- Investors Count 4
All 1 funding rounds of Synvect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $3M | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Synvect
Synvect has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, Antler and NuFund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investing and founder support services are offered globally by Antler. | 2018 | antler.co | ||
Technology sectors are invested in by NuFund venture capital firm. | nufund.com | San Diego, United States | ||
| redbud.vc | ||||
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for Synvect
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Synvect
2 dated milestones of Synvect across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Synvect is founded.
- Funding First funding round of $3.0M.
Competitors of Synvect
Synvect has 3 listed competitors in our database, 1 of them funded. They include Biota, BaseTrace and Integrated Lipid Biofuels.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biota.com | 2013 | San Diego, United States | 126 | Environmental genomics services are delivered to the petroleum industry. | ||
| basetrace.com | 2012 | Durham, United States | $20,000 | Provides DNA-based tracing solutions for effective environmental monitoring and analysis. | ||
| ilbllc.com | 2018 | Pullman, United States | Develops innovative biopolymer technologies to produce sustainable biofuel feedstocks. |
Detailed competitors of Synvect
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Synvect (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synvect
Complete news archive for Synvect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synvect
Synvect was founded in 2022 and raised its 1st funding round 3 years after it was founded.
Synvect is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Synvect is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Seed of $3M, raised on Mar 2025.
Synvect was founded in 2022 in San Diego, United States, within the biotechnology sector. Operations focus on genetic modification of mosquito eggs using CRISPR knockouts to produce sterile, non-biting male mosquitoes. These males are released to mate with wild populations, thereby suppressing mosquito numbers and limiting disease transmission. Eggs are modified in laboratories and packaged for distribution and deployment worldwide.
Synvect's top competitors include Biota, BaseTrace and Integrated Lipid Biofuels.
Synvect offers Suppression Box.
Synvect has 4 investors. Key investors include Gates Foundation, Antler, NuFund, and Redbud VC.